Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
24,139
Total Claims
$1.0M
Drug Cost
2,051
Beneficiaries
$508
Cost/Patient
Risk Score Breakdown 12/100
Score components are additive. Read full methodology
Peer Comparison vs. 2,621 Pain Management providers
+30%
Opioid rate vs peers
53.5% vs 41.3% avg
+27%
Cost per patient vs peers
$508 vs $399 avg
+9%
Brand preference vs peers
4.1% vs 3.8% avg
Opioid Prescribing
53.5%
Opioid Rate
12,903
Opioid Claims
$628K
Opioid Cost
13.2%
Long-Acting Rate
This provider's opioid prescribing rate of 53.5% is above the 20% threshold that CMS considers elevated.
Brand vs Generic
Brand: 991 claims · $500K
Generic: 23,148 claims · $541K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Oxycodone Myristate | 439 | $214K |
| Hydrocodone/Acetaminophen | 5,588 | $137K |
| Oxycodone Hcl/Acetaminophen | 4,076 | $137K |
| Naloxegol Oxalate | 134 | $57K |
| Buprenorphine Hcl | 70 | $51K |
| Gabapentin | 3,080 | $44K |
| Buprenorphine Hcl/Naloxone Hcl | 44 | $34K |
| Pregabalin | 1,582 | $32K |
| Buprenorphine Hcl/Naloxone Hcl | 132 | $30K |
| Methylnaltrexone Bromide | 11 | $28K |
| Oxycodone Hcl | 49 | $21K |
| Diclofenac Sodium | 358 | $19K |
| Buprenorphine Hcl/Naloxone Hcl | 25 | $16K |
| Tizanidine Hcl | 1,781 | $15K |
| Morphine Sulfate | 863 | $14K |
Prescribing Profile
44
Unique Drugs
12.0
Anomaly Score
Patient Profile
67
Avg Age
62%
Female
2.17
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About